Eli Lilly Collaborates with OpenAI to Combat Drug-Resistant Bacteria

Jun 25, 2024, 02:02 PM

Eli Lilly has announced a collaboration with OpenAI to discover novel medicines targeting drug-resistant bacteria. The partnership will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials aimed at treating drug-resistant pathogens. This initiative marks a significant step in the fight against drug-resistant bacteria, which pose a growing threat to global health.